(Q33803922)

29 July 2017

1 reference

title

Activation of the immune system in cancer patients (English)

1 reference

29 July 2017

Van Gool SW

1

1 reference

PubMed ID

10611577

29 July 2017

Van Den Hove L

series ordinal

2

1 reference

PubMed ID

10611577

29 July 2017

Ceuppens JL

series ordinal

3

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

Pediatric Blood Cancer

1 reference

29 July 2017

34

1 reference

29 July 2017

1

1 reference

29 July 2017

1-9

1 reference

Identifying strategies for immune intervention

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Roles of multiple accessory molecules in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Molecules involved in T-cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Signals arising from antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

The role of the CD28 receptor during T cell responses to antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

The B7 and CD28 receptor families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

CD28-B7 interactions in T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Accessory signalling by B7-1 for T cell activation induced by anti-CD2: evidence for IL-2-independent CTL generation and CsA-resistant cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Immune regulation by CD40 and its ligand GP39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Activation of human dendritic cells through CD40 cross-linking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Acquisition of lymphokine-producing phenotype by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Cyclosporin A increases IFN-gamma production by T cells when co-stimulated through CD28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Multivariate reconstruction of lymphocyte profiles in a two-dimensional graphical model as a tool for the investigation of lymphocyte subset distribution in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Human glioblastoma cell derived transforming growth factor-beta 2: evidence for secretion of both high and low molecular weight biologically active forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Gangliosides and antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

The Fas counterattack: cancer as a site of immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Dendritic cells as adjuvants for immune-mediated resistance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

A cell culture model for T lymphocyte clonal anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: evidence for systemic activation of the T cell compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

CD57+/CD28- T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Biosynthesis and shedding of murine lymphoma gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Postoperative radiotherapy in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200001%2934%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-L

10.1002/(SICI)1096-911X(200001)34:1<1::AID-MPO1>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10611577